Twitter Co-Founder Biz Stone Invests In Indian AI-Based Health Startup Visit

biz stone
Visit’s Anurag Verma (extreme left) with Twitter’s Biz Stone (centre).

Twitter, Medium and Jelly co-founder Biz Stone has invested in a Delhi-based artificial intelligence-powered chatbot Visit. This news comes hot on the heels of other tech giants investing in Indian startups.

Visit, a brainchild of students from Birla Institute of Technology and Science (BITS), Pilani, is about connecting patients and doctors via an AI-powered chatbot. Users here can get health advice, and assistance, and information from noted doctors.

Visit is an AI-powered chatbot where people interact by sharing symptoms. The bot follows up with relevant questions to collect more symptoms and risk factors, for example, is the person hypertensive, diabetic, a smoker, etc. The bot thus decides the order of treatment via conversational and low stress method.

AIM Daily XO

Join our editors every weekday evening as they steer you through the most significant news of the day, introduce you to fresh perspectives, and provide unexpected moments of joy
Your newsletter subscriptions are subject to AIM Privacy Policy and Terms and Conditions.

In a blog post titled, Why I’m Investing in Visit, Stone wrote, “Visit is a startup in India that amplifies humanity — while solving a very big and serious problem. Visit plans to democratise healthcare by shrinking the shortage of doctors using AI.”

Download our Mobile App

Quoting World Health Organisation and other studies, Stone said the world suffers from a shortage of at least 7.2 million health-care workers. “In India, for every doctor there are 2,000 patients lined up in-clinics — waiting for hours. Accessibility to quality health advice is an overwhelming problem in a country with over 200 million people affected by lifestyle problems like stress, chronic conditions, obesity, skin conditions, and more. This is where the technology approach by Visit comes in,” he wrote.

Shashvat Tripathi, 25, head of technology at Visit, told a news wire, “The bot learns about conditions and their associated symptoms by parsing millions of live chats on the Visit app and uses its NLP engine to extract information about symptoms and possible diagnoses by the doctor… It does not throw up stored responses to questions, but learns from the answers given by the user, which makes it unique.”

According to the report, Visit currently has a pool of 2,200 doctors which include psychologists, dieticians, dermatologists, sexologists, gynaecologists, preventive cardiology and paediatrician, apart from general physicians.

Sign up for The Deep Learning Podcast

by Vijayalakshmi Anandan

The Deep Learning Curve is a technology-based podcast hosted by Vijayalakshmi Anandan - Video Presenter and Podcaster at Analytics India Magazine. This podcast is the narrator's journey of curiosity and discovery in the world of technology.

Prajakta Hebbar
Prajakta is a Writer/Editor/Social Media diva. Lover of all that is 'quaint', her favourite things include dogs, Starbucks, butter popcorn, Jane Austen novels and neo-noir films. She has previously worked for HuffPost, CNN IBN, The Indian Express and Bose.

Our Upcoming Events

24th Mar, 2023 | Webinar
Women-in-Tech: Are you ready for the Techade

27-28th Apr, 2023 I Bangalore
Data Engineering Summit (DES) 2023

23 Jun, 2023 | Bangalore
MachineCon India 2023 [AI100 Awards]

21 Jul, 2023 | New York
MachineCon USA 2023 [AI100 Awards]

3 Ways to Join our Community

Telegram group

Discover special offers, top stories, upcoming events, and more.

Discord Server

Stay Connected with a larger ecosystem of data science and ML Professionals

Subscribe to our Daily newsletter

Get our daily awesome stories & videos in your inbox

Council Post: The Rise of Generative AI and Living Content

In this era of content, the use of technology, such as AI and data analytics, is becoming increasingly important as it can help content creators personalise their content, improve its quality, and reach their target audience with greater efficacy. AI writing has arrived and is here to stay. Once we overcome the initial need to cling to our conventional methods, we can begin to be more receptive to the tremendous opportunities that these technologies present.